Finally, we tested if clinically achievable dose (50μM) of vismodegib exerts an effect on cellular proliferation and apoptosis of GBM neurospheres in vitro irrespective of their relative endogenous levels of GLI1 mRNA expression. This evidence concerns the gene GLI1 and glioblastoma.